Clinical Trials Directory

Trials / Unknown

UnknownNCT05994417

Beyond Race: Objectively Assessed Skin Color and Its Association With Pulse Oximeter Bias in Critically Ill Infants

Objectively Assessed Skin Color and Its Association With Pulse Oximeter Bias in Critically Ill Infants

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Arkansas Children's Hospital Research Institute · Academic / Other
Sex
All
Age
3 Months
Healthy volunteers
Not accepted

Summary

The overall objective of this proposal is to quantify the bias in pulse oximeter reported oxygen saturation (SpO2) by evaluating its measures compared to the gold standard blood gas measured arterial oxygen saturation (SaO2) across race and skin pigmentation. The main question that the investigators intend to answer is whether 1. There is greater pulse oximeter bias and subclinical hypoxemia in (1a) Black compared to White infants, and (1b) dark versus light-pigmented infants 2. This bias increases with gestational and postnatal maturation 3. This bias is associated with adverse patient outcomes

Detailed description

The study investigators will conduct a prospective observational study involving 200 infants (0-3 months age) and compare simultaneously obtained pulse oximeter readings (SpO2) and co-oximeter measured blood gas arterial oxygen saturation (SaO2), among infants identified as Non-Hispanic Black and Non-Hispanic White. The investigators will also obtain an objective assessment of skin pigmentation using a non-invasive device, SkinColorCatch® (by Delfin Technologies Ltd, Finland) that provides (1) a melanin index and (2) an objective six-point categorization of skin color based on Individual Typology Angle (ITA). Therefore, the investigators will measure the pulse oximeter bias (SpO2-SaO2) across infants identified as Non-Hispanic Black and Non-Hispanic White, as well as among infants of various skin pigmentation. For infants that have an arterial line for more than one week, the researchers will measure pulse oximeter bias (SpO2-SaO2) on a weekly basis over time with skin maturation and pigmentation changes.

Conditions

Timeline

Start date
2023-08-15
Primary completion
2025-06-30
Completion
2025-12-31
First posted
2023-08-16
Last updated
2023-08-16

Source: ClinicalTrials.gov record NCT05994417. Inclusion in this directory is not an endorsement.